TDCS Clinical Trials 2024

TDCS Clinical Trials 2024

TDCS research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in transcranial direct current stimulation clinical trials today.

TDCS Clinical Trials

Here are the 6 most popular medical studies for tdcs

Popular filter options for tdcs trials

Ischemic Stroke Clinical Trials

View 11 Ischemic Stroke medical studies.

Stroke Clinical Trials

View 10 Stroke medical studies.

Transcranial Direct Current Stimulation Clinical Trials With No Placebo

View 72 transcranial direct current stimulation medical studies that do not have a placebo group.

View More Tdcs Trials

See another 50 medical studies focused on tdcs.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to tdcs

What are the top hospitals conducting tdcs research?

Groundbreaking clinical trials are underway at top hospitals around the world, aiming to unlock the potential of transcranial direct current stimulation (tdcs) in medical treatments. In Houston, The University of Texas Health Science Center takes center stage with three active tdcs trials, demonstrating their commitment to exploring this innovative technique that involves applying a low-level electrical current to specific areas of the brain. Similarly, in Sacramento's Imaging Research Center, researchers are conducting three ongoing tdcs trials as they delve into the possibilities offered by this non-invasive procedure. Massachusetts General Hospital in Boston also joins the ranks with its own trio of active tdcs studies, showcasing their dedication to pushing boundaries and discovering new therapeutic avenues for various conditions.

Further east in Baltimore's Johns Hopkins Hospital and Toronto's Sunnybrook Health Sciences Centre, two more leading institutions are delving into the potential benefits of tdcs. With two active trials each, these hospitals are making strides towards understanding how targeted electrical stimulation can impact brain function and potentially revolutionize treatment options across a range of disorders.

Though still early on in their journey with no historical record yet established for tdcs research specifically within these hospitals' walls; it is important to acknowledge that research is ever-evolving field where every small step taken brings us closer than before towards enhancing our understanding concerning novel methodologies like tDCS which holds immense promise not only for individuals suffering from neurological disorders but possibly expanding applications beyond realms we currently comprehend. As scientists continue working diligently at these esteemed institutions worldwide - collectively pooling resources while pioneering advancements - they pave way forward toward improving quality life countless patients globally face today

Which are the best cities for tdcs clinical trials?

When it comes to tdcs clinical trials, several cities have emerged as leaders in research and development. Toronto, Ontario stands out with 6 active trials focusing on interventions like Active tDCS + Language Therapy and Physiotherapy + Active tDCS. Houston, Texas follows closely with 4 ongoing studies examining treatments such as Transcranial Direct Current Stimulation (tDCS) and 2 mA tDCS + mCIMT. Boston, Massachusetts also has 4 active trials exploring Noninvasive Brain Stimulation without visual training and Transcranial Direct Current Stimulation. Minneapolis, Minnesota and New york City each have their share of important studies as well. These cities provide individuals seeking innovative tDCS treatments access to cutting-edge clinical trials that contribute to advancements in care and potential breakthroughs for various conditions.

Which are the top treatments for tdcs being explored in clinical trials?

In the realm of clinical trials, several cutting-edge treatments are being explored for transcranial direct current stimulation (tdcs). Among the top contenders are:

  • Repetitive tDCS: actively investigated in 10 trials
  • Dual-tDCS: under scrutiny in 6 ongoing studies
  • High-definition tDCS: gaining momentum with 4 active trials

These innovative approaches hold promise for advancing our understanding and utilization of tDCS as a potential therapeutic intervention.

What are the most recent clinical trials for tdcs?

Exciting advancements are underway in the realm of transcranial direct current stimulation (tdcs), with recent clinical trials shedding light on its potential applications. One study explored the efficacy of tDCS for various conditions, progressing through Phase 1 and Phase 2 trials since September 2023. Another trial investigated real tDCS stimulation in a Phase 2 study starting in May 2023. Furthermore, an active tDCS trial encompassing both Phase 1 and Phase 2 has been available since January 2023. These studies showcase promising outcomes for using tDCS as a therapeutic modality. With ongoing research efforts like remotely supervised tDCS alongside word-naming practice, initiated in November 2022 during a Phase 2 trial, progress towards harnessing the full potential of this technology continues to evolve steadily.

What tdcs clinical trials were recently completed?

Recently completed clinical trials in the field of transcranial direct current stimulation (tdcs) have yielded valuable insights and potential advancements. While specific details may vary, a selection of notable trials include those exploring tDCS for depression, chronic pain management, and cognitive enhancement. These studies represent significant efforts by researchers to investigate the efficacy and safety of tDCS as a therapeutic intervention.